Regeneron Pharmaceuticals (REGN) Return on Capital Employed Growth (3y) (2013 - 2026)
Regeneron Pharmaceuticals (REGN) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 4,853.00 |
| 10 | Revolution Medicines | 37.14 Bn | 37.14 Bn | - | -3,782.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -649.00 |
| Dec 31, 2025 | -879.00 |
| Sep 30, 2025 | -1,476.00 |
| Jun 30, 2025 | -1,765.00 |
| Mar 31, 2025 | -2,849.00 |
| Dec 31, 2024 | -3,153.00 |
| Sep 30, 2024 | -2,762.00 |
| Jun 30, 2024 | -2,971.00 |
| Mar 31, 2024 | -1,522.00 |
| Dec 31, 2023 | -1,182.00 |
| Sep 30, 2023 | -871.00 |
| Jun 30, 2023 | -842.00 |
| Mar 31, 2023 | -169.00 |
| Dec 31, 2022 | 73.00 |
| Sep 30, 2022 | 627.00 |
| Jun 30, 2022 | 993.00 |
| Mar 31, 2022 | 1,704.00 |
| Dec 31, 2021 | 1,760.00 |
| Sep 30, 2021 | 1,334.00 |
| Jun 30, 2021 | 1,456.00 |